Concise review: Parthenote stem cells for regenerative medicine: Genetic, epigenetic, and developmental features

Stem Cells Translational Medicine

Volumn 3, Issue 3, 2014, Pages 290-298

  Daughtry, Brittany ^a,b,c   Mitalipov, Shoukhrat ^a,b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Histocompatibility; Imprinting; Parthenogenesis; Pluripotent stem cells

Indexed keywords

CYTOSTATIC AGENT; LEUKOCYTE ANTIGEN; MATURATION PROMOTING FACTOR;

ARTICLE; CELL MATURATION; CELL THERAPY; DEVELOPMENTAL BIOLOGY; EMBRYONIC STEM CELL; EPIGENETICS; FERTILIZATION; GENETIC ANALYSIS; GENOME IMPRINTING; HETEROZYGOSITY; IMMUNE RESPONSE; MOLECULAR GENETICS; PARTHENOGENESIS; PARTHENOTE STEM CELL; REGENERATIVE MEDICINE; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL CULTURE; STEM CELL TRANSPLANTATION;

HISTOCOMPATIBILITY; IMPRINTING; PARTHENOGENESIS; PLURIPOTENT STEM CELLS;

ANIMALS; CELL LINEAGE; CELL- AND TISSUE-BASED THERAPY; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HETEROZYGOTE; HLA ANTIGENS; HOMOZYGOTE; HUMANS; PARTHENOGENESIS; PLOIDIES; REGENERATIVE MEDICINE;

EID: 84896279403     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0127     Document Type: Article

References (100)

1. Schwartz SD, Hubschman JP, Heilwell G et al. Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet 2012; 379:713-720.
2. Advanced Cell Technology. Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD). Available at http://clinicaltrials.gov/show/ NCT01469832. Accessed July 8, 2013.
3. Drukker M, Benvenisty N. The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol 2004;22:136-141.
4. Yamanaka S, BlauHM. Nuclear reprogramming to a pluripotent state by three approaches. Nature 2010;465:704-712.
5. Hanna JH, Saha K, Jaenisch R. Pluripotency and cellular reprogramming: Facts, hypotheses, unresolved issues. Cell 2010;143:508-525.
6. Robinton DA, Daley GQ. The promise of induced pluripotent stem cells in research and therapy. Nature 2012;481:295-305.
7. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008;132:567-582.
8. TachibanaM, Amato P, SparmanMet al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell 2013;153:1228-1238.
9. Cyranoski D. Stem cells cruise to clinic. Nature 2013;494:413.
10. Chapman DD, Shivji MS, Louis E et al. Virgin birth in a hammerhead shark. Biol Lett 2007; 3:425-427.
11. Crews D, Grassman M, Lindzey J. Behavioral facilitation of reproduction in sexual and unisexual whiptail lizards. Proc Natl Acad Sci USA 1986;83:9547-9550.
12. Saunders CM, Larman MG, Parrington J et al. PLC zeta: A sperm-specific trigger of Ca (2+) oscillations in eggs and embryo development. Development 2002;129:3533-3544.
13. Fan HY, Huo LJ, Meng XQ et al. Involvement of calcium/calmodulin-dependent protein kinase II (CaMKII) in meiotic maturation and activation of pig oocytes. Biol Reprod 2003;69:1552-1564.
14. Ducibella T, Fissore R. The roles of Ca2+, downstream protein kinases, and oscillatory signaling in regulating fertilization and the activation of development. Dev Biol 2008;315: 257-279.
15. Tachibana M, Amato P, SparmanMet al. Towards germline gene therapy of inherited mitochondrial diseases. Nature 2013;493: 627-631.
16. Tachibana M, Sparman M, Sritanaudomchai H et al. Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 2009;461:367-372.
17. Dighe V, Clepper L, Pedersen D et al. Heterozygous embryonic stem cell lines derived from nonhuman primate parthenotes. STEM CELLS 2008;26:756-766.
18. Mitalipov SM, Nusser KD, Wolf DP. Parthenogenetic activation of rhesus monkey oocytes and reconstructed embryos. Biol Reprod 2001;65:253-259.
19. Paull D, EmmanueleV, WeissKAet al. Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants. Nature 2013;493:632-637.
20. Susko-Parrish JL, Leibfried-Rutledge ML, Northey DL et al. Inhibition of protein kinases after an induced calcium transient causes transition of bovine oocytes to embryonic cycles without meiotic completion. Dev Biol 1994; 166:729-739.
21. Kim K, Ng K, Rugg-Gunn PJ et al. Recombination signatures distinguish embryonic stem cells derived by parthenogenesis and somatic cell nuclear transfer. Cell Stem Cell 2007;1: 346-352.
22. Kim K, Lerou P, Yabuuchi A et al. Histocompatible embryonic stem cells by parthenogenesis. Science 2007;315:482-486.
23. Leeb M, Wutz A. Derivation of haploid embryonic stem cells from mouse embryos. Nature 2011;479:131-134.
24. Latham KE, Akutsu H, Patel B et al. Comparisonofgeneexpressionduringpreimplantation development between diploid and haploidmouse embryos. Biol Reprod 2002;67:386-392.
25. Elling U, Taubenschmid J, Wirnsberger G et al. Forward and reverse genetics through derivation of haploid mouse embryonic stem cells. Cell Stem Cell 2011;9:563-574.
26. Yang H, Shi L, Wang BA et al. Generation of genetically modified mice by oocyte injection of androgenetic haploid embryonic stem cells. Cell 2012;149:605-617.
27. Li W, Shuai L, Wan H et al. Androgenetic haploid embryonic stem cells produce live transgenic mice. Nature 2012;490:407-411.
28. Leeb M, Walker R, Mansfield B et al. Germline potential of parthenogenetic haploid mouse embryonic stem cells. Development 2012;139:3301-3305.
29. Sritanaudomchai H, MaH, Clepper L et al. Discovery of a novel imprinted gene by transcriptional analysis of parthenogenetic embryonic stem cells. Hum Reprod 2010;25: 1927-1941.
30. Lin G, OuYang Q, Zhou X et al. A highly homozygous and parthenogenetic human embryonic stem cell line derived from a onepronuclear oocyte following in vitro fertilization procedure. Cell Res 2007;17:999-1007.
31. Kaufman MH, Barton SC, Surani MA. Normal postimplantation development of mouse parthenogenetic embryos to the forelimb bud stage. Nature 1977;265:53-55.
32. Surani MA, Barton SC, Norris ML. Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature 1984;308:548-550.
33. McGrath J, Solter D. Completionofmouse embryogenesis requires both the maternal and paternal genomes. Cell 1984;37:179-183.
34. Surani MA, Barton SC, Norris ML. Nuclear transplantation in the mouse: Heritable differences between parental genomes after activation of the embryonic genome. Cell 1986;45: 127-136.
35. Tarkowski AK, Witkowska A, Nowicka J. Experimental partheonogenesis in the mouse. Nature 1970;226:162-165.
36. Allen ND, Barton SC, Hilton K et al. A functional analysis of imprinting in parthenogenetic embryonic stem cells. Development 1994;120: 1473-1482.
37. Fundele RH, Norris ML, Barton SC et al. Temporal and spatial selection against parthenogenetic cells during development of fetal chimeras. Development 1990;108:203-211.
38. Keverne EB. Importance of the matriline for genomic imprinting, brain development and behaviour. Philos Trans R Soc Lond B Biol Sci 2013;368:20110327.
39. Chen Z, Liu Z, Huang J et al. Birth of parthenote mice directly from parthenogenetic embryonic stem cells. STEM CELLS 2009;27: 2136-2145.
40. Kang L, Wang J, Zhang Y et al. iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 2009;5:135-138.
41. Strain L, Warner JP, Johnston T et al. Ahuman parthenogenetic chimaera. Nat Genet 1995;11:164-169.
42. Linder D, McCaw BK, Hecht F. Parthenogenic origin of benign ovarian teratomas. NEngl J Med 1975;292:63-66.
43. Oliveira FG, Dozortsev D, Diamond MP et al. Evidence of parthenogenetic origin of ovarian teratoma: Case report. Hum Reprod 2004;19:1867-1870.
44. Lee YH, Kim SG, Choi SH et al. Ovarian mature cystic teratoma containing homunculus: A case report. J KoreanMedSci 2003;18:905-907.
45. Weiss JR, Burgess JR, Kaplan KJ. Fetiform teratoma (homunculus). Arch Pathol Lab Med 2006;130:1552-1556.
46. Greenberg JA, Clancy TE. Fetiform teratoma (homunculus). Rev Obstet Gynecol 2008;1:95-96.
47. Kuno N, Kadomatsu K, NakamuraMet al. Mature ovarian cystic teratoma with a highly differentiated homunculus: A case report. Birth Defects Res A Clin Mol Teratol 2004;70:40-46.
48. KonoT. Genomic imprinting is a barrier to parthenogenesis in mammals. Cytogenet Genome Res 2006;113:31-35.
49. Kaneko-Ishino T, Kohda T, Ishino F. The regulation and biological significance of genomic imprinting in mammals. J Biochem 2003; 133:699-711.
50. Barlow DP, Stöger R, Herrmann BG et al. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 1991;349:84-87.
51. DeChiara TM, Robertson EJ, Efstratiadis A. Parental imprinting of the mouse insulinlike growth factor II gene. Cell 1991;64:849-859.
52. Ferguson-Smith AC, Cattanach BM, Barton SC et al. Embryological and molecular investigations of parental imprinting on mouse chromosome 7. Nature 1991;351: 667-670.
53. Bartolomei MS, Zemel S, Tilghman SM. Parental imprinting of the mouse H19 gene. Nature 1991;351:153-155.
54. Geneimprint. Imprinted Genes: by Species. Available at http://www.geneimprint.org/ site/genes-by-species. Accessed February 14, 2013.
55. Ogawa H, Shindo N, Kumagai T et al. Developmental ability of trophoblast stem cells in uniparental mouse embryos. Placenta 2009;30: 448-456.
56. Kono T, Sotomaru Y, Katsuzawa Y et al. Mouse parthenogenetic embryos with monoallelic H19 expression can develop to day 17.5 of gestation. Dev Biol 2002;243:294-300.
57. Kono T, Obata Y, Yoshimzu T et al. Epigenetic modifications during oocyte growth correlates with extended parthenogenetic development in the mouse. Nat Genet 1996;13:91-94.
58. Obata Y, Kaneko-Ishino T, Koide T et al. Disruption of primary imprinting during oocyte growth leads to the modified expression of imprinted genes during embryogenesis. Development 1998;125:1553-1560.
59. Constância M, Hemberger M, Hughes J et al. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 2002; 417:945-948.
60. Sibley CP, Coan PM, Ferguson-Smith AC et al. Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta. Proc Natl Acad Sci USA 2004;101:8204-8208.
61. Li L, Keverne EB, Aparicio SA et al. Regulation of maternal behavior and offspring growth by paternally expressed Peg3. Science 1999;284:330-333.
62. Plagge A, Gordon E, Dean W et al. The imprinted signaling protein XL alpha s is required for postnatal adaptation to feeding. Nat Genet 2004;36:818-826.
63. Edwards CA, Rens W, Clarke O et al. The evolution of imprinting: Chromosomal mapping of orthologues of mammalian imprinted domains in monotreme and marsupial mammals. BMC Evol Biol 2007;7:157.
64. Renfree MB, Suzuki S, Kaneko-Ishino T. The origin and evolution of genomic imprinting and viviparity in mammals. Philos Trans R Soc Lond B Biol Sci 2013;368:20120151.
65. Moore T, Haig D. Genomic imprinting in mammalian development: A parental tug-ofwar. Trends Genet 1991;7:45-49.
66. Kawahara M, Wu Q, Takahashi N et al. High-frequency generation of viable mice from engineered bi-maternal embryos. Nat Biotechnol 2007;25:1045-1050.
67. Kawahara M, Kono T. Longevity in mice without a father. Hum Reprod 2010;25: 457-461.
68. Jiang YH, Bressler J, Beaudet AL. Epigenetics and human disease. Annu Rev Genomics Hum Genet 2004;5:479-510.
69. Cibelli JB, Cunniff K, Vrana KE. Embryonic stem cells from parthenotes. Methods Enzymol 2006;418:117-135.
70. Mai Q, Yu Y, Li T et al. Derivation of human embryonic stem cell lines from parthenogenetic blastocysts. Cell Res 2007;17: 1008-1019.
71. Horii T, Kimura M, Morita S et al. Loss of genomic imprinting in mouse parthenogenetic embryonic stem cells. STEM CELLS 2008;26: 79-88.
72. Cibelli JB, Grant KA, Chapman KB et al. Parthenogenetic stem cells in nonhuman primates. Science 2002;295:819.
73. Gonzalez R, Garitaonandia I, Abramihina T et al. Deriving dopaminergic neurons for clinical use: A practical approach. Sci Rep 2013;3: 1463.
74. Vrana KE, Hipp JD, GossAMet al. Nonhuman primate parthenogenetic stem cells. Proc Natl Acad Sci USA 2003;100(suppl 1): 11911-11916.
75. Sánchez-Pernaute R, Studer L, Ferrari D et al. Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (cyno-1) after transplantation. STEM CELLS 2005;23:914-922.
76. Didié M, Christalla P, RubartMet al. Parthenogenetic stem cells for tissue-engineered heart repair. J Clin Invest 2013;123:1285-1298.
77. Liu Y, Ye X, MaoL et al. Transplantation of parthenogenetic embryonic stem cells ameliorates cardiac dysfunction and remodelling after myocardial infarction. Cardiovasc Res 2013;97: 208-218.
78. Eckardt S, Leu NA, BradleyHL et al. Hematopoietic reconstitution with androgenetic and gynogenetic stem cells. Genes Dev 2007;21: 409-419.
79. Rao MS, Auerbach JM. Estimating human embryonic stem-cell numbers. Lancet 2006; 367:650.
80. Bray RA, Hurley CK, Kamani NR et al. National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants. Biol Blood Marrow Transplant 2008;14:45-53.
81. Nakajima F, Tokunaga K, Nakatsuji N. Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy. STEM CELLS 2007; 25:983-985.
82. Taylor CJ, Bolton EM, Pocock S et al. Banking on human embryonic stem cells: Estimating the number of donor cell lines needed for HLA matching. Lancet 2005;366:2019-2025.
83. Höglund P, Sundbäck J, Olsson-Alheim MY et al. Host MHC class I gene control of NKcell specificity in the mouse. Immunol Rev 1997;155:11-28.
84. KnudsonAGJr. Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-823.
85. Qin H, Yu T, Qing T et al. Regulation of apoptosisand differentiationby p53inhumanembryonic stem cells. J Biol Chem 2007;282: 5842-5852.
86. Lin T, Chao C, Saito S et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005;7:165-171.
87. Gore A, Li Z, Fung HL et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 2011;471:63-67.
88. Laurent LC, Ulitsky I, Slavin I et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011;8:106-118.
89. Joung JK, Sander JD. TALENs: A widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol 2013;14:49-55.
90. Urnov FD, Rebar EJ, HolmesMCet al. Genome editing with engineered zinc finger nucleases. Nat Rev Genet 2010;11:636-646.
91. Young MA, Larson DE, Sun CW et al. Backgroundmutations inparental cellsaccountformost of thegeneticheterogeneityof inducedpluripotent stem cells. Cell Stem Cell 2012;10:570-582.
92. Abyzov A, Mariani J, Palejev D et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 2012;492:438-442.
93. Martins-Taylor K, Nisler BS, Taapken SM et al. Recurrent copy number variations in human induced pluripotent stem cells. Nat Biotechnol 2011;29:488-491.
94. Hussein SM, Batada NN, Vuoristo S et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011; 471:58-62.
95. Zhao T, Zhang ZN, Rong Z et al. Immunogenicity of induced pluripotent stem cells. Nature 2011;474:212-215.
96. Hayashi K, Ohta H, Kurimoto K et al. Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell 2011;146:519-532.
97. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007;448:313-317.
98. Guha P, Morgan JW, Mostoslavsky G et al. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell 2013;12: 407-412.
99. Araki R, Uda M, Hoki Y et al. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 2013;494: 100-104.
100. Kim K, Doi A, Wen B et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010;467:285-290.